Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|March 15, 2023
Pseudotyped Viruses for InfluenzaJoanne Marie M Del Rosario, Kelly A S da Costa, Nigel J Temperton
Oxford Open Immunology|February 27, 2023
SARS-CoV-2 immunity and vaccine strategies in people with HIVClaire Mullender, Kelly A S da Costa, Aljawharah Alrubayyi, et al.
Pathogens (Basel, Switzerland)|August 29, 2024
Conference Report: LPMHealthcare Emerging Viruses 2023 (EVOX23): Pandemics-Learning from the Past and Present to Prepare for the FutureFern Jenkins, Tobias Mapulanga, Gauri Thapa, et al.
Frontiers in Immunology|February 28, 2022
AutoPlate: Rapid Dose-Response Curve Analysis for Biological AssaysPhil Palmer, Joanne Marie M Del Rosario, Kelly A S da Costa, et al.
Frontiers in Immunology|June 10, 2021
Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance StudiesFrancesca Ferrara, Joanne Marie M Del Rosario, Kelly A S da Costa, et al.
Vaccines|September 23, 2022
Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine DesignKelly A S da Costa, Joanne Marie M Del Rosario, Matteo Ferrari, et al.
Frontiers in Immunology|July 3, 2025
Wuhan strain of SARS-CoV-2 triggers activation of immune evasion machinery similar to the one operated by cancer cellsMaryam Abooali, Inna M Yasinska, Gauri Thapa, et al.
Scientific Reports|February 15, 2024
A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administrationAnna L Beukenhorst, Jacopo Frallicciardi, Keira L Rice, et al.
Vaccines|August 6, 2021
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen SelectionJoanne Marie M Del Rosario, Kelly A S da Costa, Benedikt Asbach, et al.
Scientific Reports|November 4, 2023
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1Aljawharah Alrubayyi, Emma Touizer, Dan Hameiri-Bowen, et al.
Pageof 2